anxiety
Medications
SN instructed patient / caregiver on Xanax / Alprazolam Which is a medication in the class of benzodiazepines. Explained that this medication is indicated in the management of anxiety and panic attacks and that it works by acting on the CNS to decrease anxiety. Explained to patient that the side effects include: dizziness, drowsiness, lethargy, headache, rashes, nausea, vomiting. Explained that abrupt discontinuation of this medication can cause withdrawal symptoms such as: sweating, nausea, vomiting, muscle cramps, tremors and seizures. Instructed patient to avoid ETOH, CNS depressants, and grapefruit juice while taking Xanax. Instructed to notify Physician if experiencing unrelieved anxiety or if experiencing persistence or worsening of medication side effects
Instructed in new medication Amoxicillin and in S/E such as lethargy, hallucinations, seizures, anxiety, confusion, agitation, depression, dizziness, fatigue, nausea, vomiting, diarrhea, glossitis, stomatitis, gastritis, abdominal pain, enterocolitis, pseudomembranous colitis, black tongue, interstitial nephritis, nephropathy, vaginitis, anemia, thrombocytopenia, thrombocytopenic purpura, eosinophilia, leukopenia, hemolytic anemia, agranulocytosis, hypersensitivity reactions, anaphylaxis, and overgrowth of nonsusceptible organisms.
Notify MD if rash, fever, or chills develop. A rash is the most common allergic reaction, especially if allopurinol is also being taken.
Instructed in new medication Avapro to manage hypertension. In addition, warned of possible S/E such as fatigue, anxiety, dizziness, headache, chest pain, edema, tachycardia, pharyngitis, rhinitis, sinus abnormality, diarrhea, dyspepsia, abdominal pain, nausea, vomiting, urinary tract infection, musculoskeletal trauma, or pain, upper respiratory tract infection, rash.
Instructed in new medication Sinemet and in S/E such as choreiform, dystonic, dyskinetic movements, involuntary grimacing, head movements, myoclonic body jerks, ataxia, tremor, muscle twitching, bradykinetic episodes, psychiatric disturbances, anxiety, disturbing dreams, euphoria, malaise, fatigue, severe depression, suicidal tendencies, dementia, delirium, hallucinations (may necessitate reduction or withdrawal of drug), confusion, insomnia, agitation, orthostatic hypotension, cardiac irregularities, phlebitis, blepharospasm, blurred vision, diplopia, mydriasis or miosis, oculogyric crises, excessive salivation, dry mouth, bitter taste, nausea, vomiting, anorexia, constipation, flatulence, diarrhea, abdominal pain, urinary frequency, urine retention, urinary incontinence, darkened urine, priapism, hemolytic anemia, thrombocytopenia, leukopenia, agranulocytosis, hepatotoxicity, weight loss (may occur at start of therapy), hiccups, hyperventilation, and dark perspiration.
Instructed in new medication Augmentin to manage infection. In addition, warned of possible S/E such as nausea, vomiting, headache, dizziness, skin rash, blurred vision, confusion, anxiety, redness, etc.
Instructed in new medication Xopenex to manage bronchospasm. In addition, warned of possible S/E such as dizziness, migraine, pain, tremor, anxiety, tachycardia, dyspepsia, leg cramps, increased cough, flu syndrome, accidental injury and viral infection.
Instructed in new medication Wellbutrin to manage depression. In addition, warned of possible S/E such as headache, seizures, anxiety, confusion, delusions, euphoria, hostility, impaired sleep quality, insomnia, sedation, tremor, akinesia, akathisia, agitation, dizziness, fatigue, syncope, fever, arrhythmias, hypertension, hypotension, palpitations, tachycardia, auditory disturbances, blurred vision, dry mouth, taste disturbance, increased appetite, constipation, dyspepsia, nausea, vomiting, anorexia, diarrhea, impotence, menstrual complaints, urinary frequency, urine retention, weight loss, weight gain, arthritis, pruritus, rash, cutaneous temperature disturbance, excessive diaphoresis, chills and decreased libido. Advised to avoid prolonged sun exposure and to use sun block.
Instructed in new medication Alprazolam to manage anxiety. In addition, warned of possible S/E such as drowsiness, light-headedness, headache, confusion, tremor, dizziness, syncope, depression, insomnia, memory impairment, nervousness, minor changes in EEG patterns, hypotension, tachycardia, blurred vision, nasal congestion, dry mouth, nausea, vomiting, diarrhea, constipation, increased salivation, weight gain or loss, muscle rigidity, dermatitis. Avoid hazardous activities that require alertness and good psychomotor coordination until CNS effects of drug are known. Avoid alcohol while taking drug. Smoking may decrease effectiveness of drug. Do not stop using drug abruptly because withdrawal symptoms or seizures may occur.
Instructed in new medication Temazepam to manage insomnia. In addition, warned of possible S/E such as drowsiness, dizziness, lethargy, disturbed coordination, daytime sedation, confusion, nightmares, vertigo, euphoria, weakness, headache, fatigue, nervousness, anxiety, depression, blurred vision, diarrhea, nausea, dry mouth, physical and psychological dependence. Avoid alcohol during therapy. Caution when performing activities that require mental alertness or physical coordination. Instructed not to discontinue drug abruptly if it is taken for 1 month or longer.
Instructed in new medication Amitriptyline to manage depression. In additon, warned of possible S/E such as coma, seizures, hallucinations, delusions, disorientation, ataxia, tremor, peripheral neuropathy, anxiety, insomnia, restlessness, drowsiness, dizziness, weakness, fatigue, headache, extrapyramidal reactions, MI, stroke, arrhythmias, heart block, orthostatic hypotension, tachycardia, ECG changes, hypertension, edema, blurred vision, tinnitus, mydriasis, increased intraocular pressure, dry mouth, nausea, vomiting, anorexia, epigastric distress, diarrhea, constipation, paralytic ileum, urine retention, agranulocytosis, thrombocytopenia, leukopenia, eosinophilia, hypoglycemia, hyperglycemia, rash, urticaria, photosensitivity, diaphoresis and hypersensitivity reaction. Instructed to take full dose at bedtime but warned patient of possible morning orthostatic hypotension. Avoid alcohol during drug therapy. Consult MD before taking other medications. Avoid activities that require alertness and good psychomotor coordination until CNS effects of drug are known. Drowsiness and dizziness usually subside after a few weeks. Dry mouth may be relieved with sugarless hard candy or gum. Saliva substitutes may be needed. Instructed to use a sun block, wear protective clothing and avoid prolonged exposure to strong sunlight. To prevent photosensitivity reactions. Do not stop drug therapy abruptly.